RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+33.59%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$380M
AUM Growth
+$380M
(+43%)
Cap. Flow
+$41.1M
Cap. Flow
% of AUM
10.83%
Top 10 Holdings %
Top 10 Hldgs %
77.18%
Holding
35
New
3
Increased
16
Reduced
6
Closed
6
Top Buys
| 1 |
Regenxbio
RGNX
|
$18.9M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$15.5M |
| 3 |
Atara Biotherapeutics
ATRA
|
$11M |
| 4 |
MDCO
Medicines Co
MDCO
|
$9.7M |
| 5 |
OraSure Technologies
OSUR
|
$7.32M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$17.2M |
| 2 |
United States Oil Fund
USO
|
$7.91M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$5.21M |
| 4 |
Omeros
OMER
|
$2.57M |
| 5 |
BLUE
bluebird bio
BLUE
|
$1.72M |
Sector Composition
| 1 | Healthcare | 89.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alnylam Pharmaceuticals
ALNY
$58.5B
| $56M | 14.74% | 1,092,516 +303,308 | +38% | +$15.5M |
|
|
AVXS
2
DELISTED
AveXis, Inc. Common Stock
AVXS
| $47.4M | 12.47% | 623,330 -225,713 | -27% | -$17.2M |
|
3
Bristol-Myers Squibb
BMY
$96B
| $31M | 8.17% | 570,692 +4,804 | +0.8% | +$261K |
|
|
LJPC
4
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $30.7M | 8.08% | 1,028,929 -57,108 | -5% | -$1.7M |
|
|
5
BioCryst Pharmaceuticals
BCRX
$1.74B
| $29M | 7.65% | 3,458,120 -620,775 | -15% | -$5.21M |
|
|
MDCO
6
DELISTED
Medicines Co
MDCO
| $28M | 7.37% | 572,689 +198,426 | +53% | +$9.7M |
|
|
7
Regenxbio
RGNX
$451M
| $23.5M | 6.18% | 1,216,505 +976,716 | +407% | +$18.9M |
|
|
8
Atara Biotherapeutics
ATRA
$84.6M
| $18.7M | 4.92% | 908,733 +536,109 | +144% | +$11M |
|
|
AGEN
9
Agenus
AGEN
$133M
| $16M | 4.21% | 4,245,882 +35,618 | +0.8% | +$134K |
|
10
PTC Therapeutics
PTCT
$3.92B
| $12.8M | 3.38% | 1,305,643 +308,477 | +31% | +$3.04M |
|
11
Incyte
INCY
$16.5B
| $11M | 2.9% | 82,490 -4,267 | -5% | -$570K |
|
|
OXFD
12
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $9.49M | 2.5% | 612,903 +69,616 | +13% | +$1.08M |
|
|
BLUE
13
DELISTED
bluebird bio
BLUE
| $9.42M | 2.48% | 103,617 -18,959 | -15% | -$1.72M |
|
14
Masimo
MASI
$7.59B
| $7.55M | 1.99% | 80,900 | – | – |
|
|
15
OraSure Technologies
OSUR
$242M
| $7.32M | 1.93% | +566,230 | New | +$7.32M |
|
|
VIVE
16
DELISTED
VIVEVE MED INC
VIVE
| $7.25M | 1.91% | 1,145,736 +306,070 | +36% | +$1.94M |
|
|
DRNA
17
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.01M | 1.85% | 2,062,991 +19,775 | +1% | +$67.2K |
|
|
CORI
18
DELISTED
Corium International, Inc.
CORI
| $6.06M | 1.59% | 1,448,991 +347,946 | +32% | +$1.45M |
|
19
Tactile Systems Technology
TCMD
$297M
| $5.46M | 1.44% | 287,876 +39,114 | +16% | +$741K |
|
20
Arbutus Biopharma
ABUS
$711M
| $4.7M | 1.24% | +1,446,587 | New | +$4.7M |
|
|
VRAY
21
DELISTED
ViewRay, Inc.
VRAY
| $4.39M | 1.16% | +515,612 | New | +$4.39M |
|
|
IVTY
22
DELISTED
Invuity, Inc
IVTY
| $3.74M | 0.98% | 470,167 +15,267 | +3% | +$121K |
|
|
GBT
23
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $965K | 0.25% | 26,183 +220 | +0.8% | +$8.11K |
|
24
Celldex Therapeutics
CLDX
$1.47B
| $873K | 0.23% | 241,699 +2,037 | +0.8% | +$7.36K |
|
|
TMBR
25
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $648K | 0.17% | 1,283,951 +10,823 | +0.9% | +$5.46K |
|